Are we entering a new age for human vaccine adjuvants?

Abstract

Major advances in adjuvant development for human vaccines have been reported recently for a range of indications, including malaria, influenza and varicella zoster virus. Furthermore, there is an increased understanding of adjuvant mechanisms of action and a greater emphasis on the importance of formulation and characterization. This progress may signify a new golden age of vaccine adjuvant discovery and development.

Keywords: MF59; MPL; QS21; formulation; vaccine adjuvant.